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OBJECTIVE: Weight management interventions during pregnancy have had limited success in reducing the risk of pregnancy
complications. Focus has now shifted to pre-pregnancy counselling to optimise body weight before subsequent conception. We
aimed to assess the effect of interpregnancy body mass index (BMI) change on the risk of perinatal complications in the second
pregnancy.
METHODS: A cohort study was performed using pooled maternity data from Aberdeen, Finland and Malta. Women with a BMI
change of ±2 kg/m2 between their first and second pregnancies were compared with those who were BMI stable (remained within
±2 kg/m2). Outcomes assessed included pre-eclampsia (PE), intrauterine growth restriction (IUGR), preterm birth, birth weight, and
stillbirth in the second pregnancy. We also assessed the effect of unit change in BMI for PE and IUGR. Logistic regression was used
to calculate odds ratios with 95% confidence intervals.
RESULTS: An increase of ≥2 kg/m2 between the first two pregnancies increased the risk of PE (1.66 (1.49–1.86)) and high
birthweight (>4000 g) (1.06 (1.03–1.10)). A reduction of ≥2 kg/m2 increased the chance of IUGR (1.15 (1.01–1.31)) and preterm birth
(1.14 (1.01–1.30)), while reducing the risk of instrumental delivery (0.75 (0.68–0.85)) and high birthweight (0.93 (0.87–0.98)).
Reducing BMI did not significantly decrease PE risk in women with obesity or those with previous PE. A history of PE or IUGR in the
first pregnancy was the strongest predictor of recurrence independent of interpregnancy BMI change (5.75 (5.30–6.24) and (7.44
(6.71–8.25), respectively).
CONCLUSION: Changes in interpregnancy BMI have a modest impact on the risk of high birthweight, PE and IUGR in contrasting
directions. However, a prior history of PE and IUGR is the dominant predictor of recurrence at second pregnancy.
International Journal of Obesity; https://doi.org/10.1038/s41366-021-00971-7
INTRODUCTION
The global pandemic of obesity and its myriad of complications
has led to it becoming a major target for public health campaigns.
Obesity during pregnancy represents an important preventable
risk factor that is strongly associated with poorer maternal and
foetal outcomes [1–5]. Unfortunately, interventions for weight loss
initiated during pregnancy remain largely ineffective in reducing
obstetric complications [6]. One possible explanation for this may
be the short time interval for any significant physiological changes
to take effect [7]. Alternatively, pre-pregnancy genetic or
metabolic factors may also determine the occurrence of such
complications and thus may not be particularly amenable to
lifestyle alterations during pregnancy. As a result, women are now
being targeted for interventions during the post-partum period in
an attempt to prevent these complications from recurring.
However, previous studies examining the effects of interpreg-
nancy weight change and the risk of subsequent pregnancy
complications are, on the whole, limited by their small sample
sizes and/or recall bias from self-reported weight or body mass
index (BMI) [8–16]. Furthermore, only a few have evaluated the
impact of interpregnancy BMI change in high-risk patient groups,
such as those with obesity or prior gestational complications [17–
19]. Therefore, a better understanding of the relationship between
interpregnancy weight change and adverse pregnancy outcomes
is vital for developing evidence-based interventions and guidance,
especially for those at high-risk of individual complications.
Avoiding the consequences of an unhealthy BMI by encoura-
ging primigravid women to obtain a healthy pre-pregnancy
weight is a high priority goal. Although a laudable aim, this is
extremely difficult given that the majority of first pregnancies are
unplanned, particularly in younger or socially deprived women
[20]. As a result, preconception care alone is no longer tenable and
more efforts, such as those targeting the interpregnancy period to
achieve a healthy body weight prior to conceiving the subsequent
pregnancy, may help reduce the overall risk of adverse perinatal
outcomes.
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Previous population-based studies have investigated interpreg-
nancy BMI/weight change and its relationship with various
pregnancy complications [11, 19, 21–28]. These studies have
shown a strong association between interpregnancy weight
change and the risk of premature delivery, pre-eclampsia (PE),
extremes of placental weight, small or large for gestational age-
births, and gestational diabetes [11, 19, 21–28]. One of the
published large population-based cohort studies utilises data from
the Swedish birth register (n= 151 025) [21] and demonstrates a
linear relationship between interpregnancy weight gain and the
first occurrence of PE during the second pregnancy. These results
were replicated within a Scottish cohort where in addition to
finding an increased risk of primary PE with interpregnancy weight
gain specific to women who were overweight or had obesity at
baseline [24], conversely demonstrated an increased risk of
primary and recurrent SGA- birth with interpregnancy weight loss
[19, 24]. As PE and IUGR or SGA frequently co-exist in pregnancies,
it is imperative to understand the effects of interpregnancy weight
change on PE and IUGR, especially in those who have previously
experienced these serious complications. The aim of this study is
to assess the effect of interpregnancy BMI change on the risk of




We conducted a cohort study using routinely collected perinatal data from
three countries: Scotland, Finland, and Malta. The population of interest
were women with records of their first two consecutive singleton
pregnancies, with no prior live or stillbirths, in the birth registries of the
three countries. Our exposure variable, interpregnancy weight change, was
estimated by calculating the difference between first and second
pregnancy maternal BMI recorded at the time of the first antenatal visit
(weight (kg)/height (m2)). Changes in BMI were categorised as; ≤2 kg/m2
(BMI reduced), −2 to 2 kg/m2 (BMI stable and reference group), and ≥2 kg/
m2 (BMI increased). BMI changes of 2 kg/m2 were selected to maintain
comparability with previous studies [19], and in consideration that a BMI
change of 1 kg/m2 equates to only 2.6 kg (assuming an average height of
1.62m) which may reflect natural weight fluctuations and not a true gain
or loss of weight. The outcomes were any adverse perinatal events in the
second pregnancy such as PE (hypertension with proteinuria during
pregnancy), placenta praevia, placental abruption, IUGR (recorded as per
ultrasound diagnosis), preterm birth (further grouped into delivery before
37/34/32 weeks of gestation), low birthweight (birth weight <2500 g), high
birth weight (>4000 g), stillbirth, and mode of delivery (vaginal,
instrumental, elective or emergency caesarean section (CS)). The following
variables were considered as potential confounders: maternal age, BMI at
first baseline pregnancy, socioeconomic status based on maternal
occupation (Finland), paternal occupation (AMND) or maternal education
(Malta), marital status, and smoking habits at the time of the second
delivery. In addition, interpregnancy interval, year of delivery of the second
baby, and the country of origin of the datasets were also tested for
potential confounding effects. Maternal age was categorised into five
categories as <20, 20–29, 30–35, 36–40 and ≥41 years. BMI was categorised
as underweight (<18.5), normal weight (18.5–24.9), overweight (25–29.9),
and obesity (≥30). Socioeconomic status was recoded into a binary
variable: deprived (yes/no). Registrar General’s fathers’ occupation-based
social class in the AMND was coded as ‘not deprived’ (I, II, IIIa) and the
remainder as ‘deprived’. Data from Finland was coded ‘upper white-collar
worker’ as ‘not deprived’, all others (lower white-collar, blue-collar and
other including student and housewife) as ‘deprived’. Maternal education
level in Malta was used as a social class with university-level education
coded as ‘not deprived’ and below this level as ‘deprived’.
Data sources
Data were obtained from three sources: the Aberdeen Maternity and
Neonatal Databank (AMND) between 1986 and 2012 [29], the Finnish
Medical Birth Register (MBR) between 2004 and 2014 [30], and the Maltese
National Obstetric Information System (NOIS) between 1999 and 2015 [31].
Finnish MBR [30] and Maltese NOIS [31] are national perinatal registers that
collect data on all maternities across the country while AMND collects data
on all births within Aberdeen City District––a defined geographical region
in the North East of Scotland [29]. De-identified data were extracted from
the three sources and pooled to form a single database after standardising
and recoding all key variables. From this database, women with
information on their first two singleton births were selected for analysis
and those with incomplete BMI records in either of their first two
pregnancies were excluded.
Statistical analysis
Descriptive statistics were presented as mean (SD) for normally distributed
continuous variables and counts and proportions for categorical variables.
Characteristics of the second pregnancy were compared between BMI stable
and BMI changed cohorts using univariable analysis, chi-square test for
categorical variables and ANOVA for continuous variables. A p value of ≤0.05
was considered statistically significant. Binary or multinomial logistic
regression was used to calculate odds ratios (OR) with 95% confidence
intervals (CI) for predefined perinatal outcomes of the second pregnancy for
each of the exposed cohorts. Models were adjusted for potential confounders
identified on univariable analysis plus the same adverse outcome in the
previous pregnancy. Low and high birth weights were also adjusted for
gestational age at delivery. We also examined weight change as a continuous
variable and calculated the risk of PE and IUGR stratified by the BMI category
in the first pregnancy. There were no data missing in the exposure and
outcome variables due to the inclusion and exclusion criteria. Complete case
analysis was performed with ≤5% of missing data in the covariates.
Ethical permissions
Permission to analyse de-identified data were obtained from the Caldicott
guardians of all three databases: the steering committee of the Aberdeen
Maternity and Neonatal Databank (AMND 3/2016); Finnish Institute for
Health and Welfare, Finland (THL 1719/5.05.00/2015); Directorate for
Health Information Research Malta (28/04/2016). As routinely collected de-
identified data were analysed, formal ethical approval was not considered
necessary by the North of Scotland Research Ethics Service. This analysis
was part of a collaborative project looking at the recurrence risk of
stillbirth.
RESULTS
After data cleaning and merging, there were 163 488 women with
both first and second pregnancy records included in the analysis
(Fig. 1). Table 1 presents the maternal characteristics at the time of
the second pregnancy by BMI change. The timing of the first
antenatal visit varied among the participants but 90% of women
attended for their first antenatal visit before 12 weeks of gestation
in both pregnancies. In the remaining 10% of late attendees, no
association was found with maternal BMI or interpregnancy BMI
change. Within the total cohort, 118,924 (72.7%) were BMI stable
across the two pregnancies, while 9 438 (5.8%) had reduced, and
35 126 (21.5%) had increased their BMI by ≥2 kg/m2. Women who
were aged <20 years were more likely to increase their BMI (0.7%
versus 1.4%) while women who were aged 20 to 29 years were
equally likely to increase or reduce their BMI (Table 1). Compared
to BMI stable women, those who increased their BMI were more
likely to fall into the overweight (18.5% versus 40.2%) or obesity
(7.0% versus 33.4%) category at the time of their second
pregnancy. On the other hand, women who reduced their BMI
were found more frequently within the underweight (3.8% versus
5.4%), overweight (18.5% versus 22.7%), or obesity (7.0% versus
12.2%) category. Women exhibiting interpregnancy weight
change were more likely to be socially deprived, smoke, and be
single. Furthermore, women who had increased their BMI were
more likely to have longer interpregnancy intervals (Table 1).
Table 2 presents the counts, proportions, and unadjusted and
adjusted ORs (95% CIs) of outcomes of the second pregnancy in
relation to interpregnancy BMI change. In comparison to weight
stable BMI women (3.0%), both a reduction (3.6%) and an increase
in BMI (5.1%) was associated with an enhanced incidence of PE
(Table 2). Reduced BMI increased the rate of IUGR (2.7% versus
2.2% in weight stable women) while an increase in BMI was
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associated with a reduction (1.7%). Reduced BMI was also
associated with a slight increase in the risk of preterm birth
before 37 weeks (2.7% versus 3.1%) and 32 weeks (0.6% versus
0.8%). Women who had reduced their BMI were more likely to be
delivered by elective or emergency CS but less likely to have an
instrumental delivery. Women who had increased their BMI were
also more likely to be delivered by both elective and emergency
CS than their BMI stable counterparts (Table 2).
After adjusting for potential confounding factors, a reduction of
≥2 kg/m2 was associated with an increased risk of IUGR (1.15
(1.01–1.31)), preterm birth before 37 weeks (1.14 (1.01–1.30)) as
well as 34 weeks (1.33 (1.04–1.72)), and a reduced chance of
instrumental delivery (0.75 (0.68–0.85)) (Table 2). Although the risk
of PE was associated with a ≥2 kg/m2 decrease on unadjusted
analysis, this was no longer statistically significant after adjust-
ment (1.12 (0.99–1.26)) (Table 2). On the other hand, a BMI
increase of ≥2 kg/m2 conferred an increased risk of PE 1.66
(1.49–1.86)), and high birthweight (1.06 (1.03–1.10)) in the second
pregnancy (Table 2).
Table 3 presents the fully adjusted models in relation to two key
clinical outcomes, PE and IUGR, with ORs for all predictor variables.
As previously shown in Table 2, women who increased their
interpregnancy BMI by ≥2 kg/m2 were found to have an increased
risk of PE on adjusted analyses (1.66 (1.49–1.86)) (Table 3). A prior
history of PE was the strongest predictor of PE in the second
pregnancy (5.75 (5.30–6.24)). In addition, increasing maternal age,
(1.04 (1.03–1.05)), BMI status at the start of the second pregnancy
(1.10 (1.09–1.11)), deprived social class (1.04 (1.02–1.05)), and an
increased interpregnancy interval (1.10 (1.08–1.12)), were signifi-
cantly associated with the occurrence of PE in the second
pregnancy (Table 3).
Similar to PE, a previous history of IUGR was the greatest
predictor of IUGR incidence in the second pregnancy (7.44
(6.71–8.25)) (Table 3). Furthermore, an interpregnancy BMI
reduction (1.15 (1.01–1.31)), a younger maternal age 0.97
(0.96–0.98), a lower BMI at the start of the second pregnancy
(1.15 (1.01–1.31)), smoking (1.05 (1.02 – 1.07)), single marital status
(1.11 (1.05–1.18)), deprived social class (1.07 (1.04–1.10)), and
increasing interpregnancy interval (1.07 (1.05– 1.10)) demon-
strated significant associations of IUGR development in the
second gestation (Table 3).
The risk of PE and IUGR in the second pregnancy for each 1 kg/
m2 increase or decrease in interpregnancy BMI is depicted in Fig.
2. Overall, as well as in each BMI category at the time of the first
pregnancy, the risk of PE increased while the chance of IUGR
reduced with every unit increase in interpregnancy BMI (Fig. 2a
and Fig. 2b). Women in the underweight category at the start of
the first pregnancy were found to be the most sensitive to this
change and possessed a 16% increased risk of PE and an 11%
reduction in the risk of IUGR per 1 kg/m2 increase in interpreg-
nancy BMI. In contrast, a 1 kg/m2 increase in interpregnancy BMI
for women in the obesity category only increased their risk of PE,
or reduced their risk of IUGR, by 6%. Similarly, reducing weight
between pregnancies was associated with a very large increase in
the risk of IUGR in underweight women but weight reduction in
women with obesity had little impact on their risk of PE (Fig. 2c
and Fig. 2d).
The association observed per 1 kg/m2 interpregnancy weight
change and high birthweight (>4000 g) is also highlighted in
Supplementary Figure 1. The risk of a birthweight >4000 g
increased with every 1 kg/m2 increase in interpregnancy BMI
except for women with obesity at the start of their first pregnancy
where the risk remained unchanged (Supplementary Figure 1).
Conversely, a 1 kg/m2 decrease in interpregnancy BMI reduced the




An analysis of pooled data from three European countries
confirmed that an interpregnancy BMI increase of ≥2 kg/m2
between the first two pregnancies increased the risk of PE and
high birth weights but did not markedly affect the risk of any
Fig. 1 Flow chart. Flow chart demonstrating participant selection from respective databases.
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other complications in the second pregnancy. In comparison, a
reduction in BMI of ≥2 kg/m2 increased the risk of IUGR and
preterm birth but reduced the risk of instrumental delivery and
high birth weights. In addition, each unit increase in BMI was
associated with an increase in the risk of PE and high birthweight
but a reduction in the risk of IUGR. On the other hand, each 1 kg/
m2 reduction, increased the risk of IUGR while decreasing the risk
of high birth weights. Women who were underweight at the start
of their first pregnancy were most sensitive to interpregnancy BMI
change. Previous pregnancy complications (PE or IUGR in the first
pregnancy) were the strongest predictor of the same complication
occurring in the next pregnancy irrespective of the interpregnancy
change in BMI.
Strengths and limitations
To our knowledge, this is the first study that investigated
individualised evidence on perinatal outcomes in relation to BMI
change between first and second pregnancies. The main strength
of our study is the use of population-based data from three
countries which provided a large representative sample for
covariate-adjusted stratified analyses as well as an increased
power of generalisability. In addition, further key strengths of this
study included robust study design, accurate data collection, and
statistical analysis. That is, all BMI data included were obtained
from accurate weight and height measurements taken at the first
antenatal visit by trained professionals which negated any recall,
reporting, and potential PE-induced fluid retention bias. The main
limitation of our results stem from the lack of standardisation in
the definition of variables across the three registries. For example,
in the Finnish registry, social class/socioeconomic position was
recorded as white/blue-collar workers according to the mother’s
occupation during pregnancy while the Maltese database used
maternal education, and the AMND by the Registrar general’s
classification based on the father’s occupation. These disparate
Table 1. Characteristics of second pregnancy in relation to BMI change.
Characteristics BMI stable Reduced BMI Increased BMI p value*
n= 118,924 (72.7%) n= 9 438 (5.8%) n= 35 126 (21.5%)
Maternal age (years) 29.82 (4.62) 28.92 (4.78) 28.99 (4.99) <0.001
<20 777 (0.7%) 99 (1.0%) 481 (1.4%)
20–29 54,761 (46.0%) 5150 (54.6%) 18,701 (53.2%)
30–35 45,001 (37.8%) 2983 (31.6%) 10,925 (31.1%)
36–40 16,129 (13.6%) 1057 (11.2%) 4349 (12.4%)
≥41 2255 (1.9%) 148(1.6%) 670 (1.9%)
BMI (kg/m2) 23.44 (4.02) 24.27 (4.08) 28.67 (5.35) <0.001
Underweight 4465 (3.8%) 509 (5.4%) 26 (0.1%)
Healthy weight 84,169 (70.8%) 5,626 (59.6%) 9266 (26.4%)
Overweight 22,011 (18.5%) 2,147 (22.7%) 14,106 (40.2%)
Obesity 8,279 (7.0%) 1,156 (12.2%) 11,728 (33.4%)
Social class <0.001
Not deprived 26,757 (22.9%) 1500 (16.2%) 5201 (15.2%)
Deprived 87,789 (75.3%) 7261 (78.6%) 28,048 (82.1%)
Missing 2116 (1.8%) 474 (5.1%) 935 (2.7%)
Smoking <0.001
Non-smoker 10,8231 (91.0%) 8055 (85.3%) 30,673 (87.3%)
Smoker 8647 (7.3%) 1239 (13.1%) 3828 (10.9%)
Missing 2046 (1.7%) 144 (1.5%) 625 (1.8%)
Marital status <0.001
Married/cohabiting 1,12,238 (94.4%) 8596 (91.1%) 32274 (91.9%)
Single 6532 (5.5%) 821 (8.7%) 2782 (7.9%)
Unknown 140 (0.1%) 20 (0.2%) 60 (0.2%)
Interpregnancy Interval <0.001
<2 years 66,153 (55.6%) 4899 (51.9%) 726 (7.7%)
2–5 years 47,335 (39.8%) 3813 (40.4%) 14,328 (40.8%)
>5 years 5434 (4.6%) 726 (7.7%) 3689 (10.5%)
Year of delivery <0.001
1986–1995 4989 (4.2%) 239 (2.5%) 1176 (3.3%)
1996–2005 8134 (6.8%) 789 (8.4%) 2917 (8.3%)
2006–2015 1,05,799 (89.0%) 8410 (89.1%) 31,032 (88.3%)
Country of origin <0.001
Aberdeen 14,538 (12.2%) 1021 (10.8%) 4616 (13.1%)
Finland 98,795 (83.1%) 7354 (77.9%) 27,940 (79.5%)
Malta 5591 (4.7%) 1063 (11.3%) 2570 (7.3%)
*Statistically significant p values (<0.001) are shown as bold.
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variables were homogenised by categorising each into a binary
variable (deprived/not deprived) however, this may still have lost
some subtle nuances in the process. Due to missing or improbable
data, we were unable to adjust for gestational weight gain, blood
pressure, and medication such as aspirin in the second pregnancy.
In addition, total gestational weight gain in the first pregnancy
and pre-existing maternal diseases such as kidney disease, or
chronic hypertension were unavailable. Moreover, gestational
diabetes mellitus (GDM) and hypertension in pregnancy were not
included due to accuracy concerns within our datasets. For
instance, some of our data pre-dates the agreed scientific
definition of GDM and due to the coding criteria for the datasets
being hierarchical such that pregnancy hypertension and protei-
nuria is classified as PE and PE and pregnancy hypertension are
mutually exclusive conditions, both GDM and pregnancy hyper-
tension could not be included. Furthermore, although access and
management of care during pregnancy are standardised in all
three countries, population differences are likely to still remain. It
should also be noted that the biggest contribution of data came
from the Finnish registry, and therefore may have overwhelmed
the smaller datasets from the two other countries. However, to
circumvent this, we accounted for the country of origin as a
covariate in the model. To mitigate any change in clinical practice
or trend in the prevalence of overweight and pregnant women
who have obesity, the year of birth was included in the
adjusted model.
Context of previous research
A search of the published literature identified three recent
systematic reviews on interpregnancy weight change and the
risk of perinatal outcomes [32–34]. With all three reporting
concordant findings based on similar primary studies [32–34], we
will focus on the largest and most robust of these. In their
systematic review with meta-analysis and meta-regression,
Timmerman et al. [32] included > 1 million pregnancies from
30 studies and reported similar findings to the results presented
here. Of note, a BMI increase of 1 kg/m2 was associated with an
increased risk of gestational diabetes and hypertension while only
increases of > 3 kg/m2 were associated with an increased risk of PE
[32]. Moreover, apart from large for date babies, weight loss did
not appear to confer any risk reduction for any other complica-
tions [32]. Within the same study, the authors found women with
a BMI < 25 kg/m2, classified as ‘normal weight’ or low-risk women,
to be at increased likelihood of subsequent pregnancy complica-
tions if they gained weight before the start of the pregnancy [32].
In smaller systematic reviews, Oteng-Ntim et al. and Teulings et al.
also report remarkably similar findings [33, 34].
Table 3. Fully adjusted models for PE and IUGR in the second
pregnancy.
Variables PE aOR (95% CI) IUGR aOR
(95% CI)
(n= 5645) (n= 3462)
BMI change
BMI reduced 1.12 (0.99–1.26) 1.15 (1.01–1.31)
BMI increased 1.66 (1.49–1.86) 0.94 (0.85–1.04)
Maternal age 1.04 (1.03–1.05) 0.97 (0.96–0.98)
BMI in 2nd pregnancy 1.10 (1.09–1.11) 0.95 (0.94–0.95)
Smoking 0.98 (0.95–1.00) 1.05 (1.02–1.07)
Marital status (single) 0.98 (0.91–1.06) 1.11 (1.05–1.18)
Deprived social class 1.04 (1.02–1.05) 1.07 (1.04–1.10)
Interpregnancy interval 1.10 (1.08–1.12) 1.07 (1.05–1.10)
Country of origin 0.92 (0.85–1.01) 1.18 (1.04–1.33)
History of same
complication
5.75 (5.30–6.24) 7.44 (6.71–8.25)
Year of birth 0.94 (0.93–0.95) 1.03 (1.02–1.04)
Statistically significant odds ratios (p < 0.001) are shown as bold.
Fig. 2 Interpregnancy BMI Unit change by BMI categories and risk of PE and IUGR. a, b Change in the risk of PE and IUGR in the second
pregnancy for unit increase in interpregnancy BMI by BMI categories in the first pregnancy. c, d Change in the risk of PE and IUGR in the
second pregnancy for unit decrease in interpregnancy BMI by BMI categories in the first pregnancy.
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Meaning of the study
In the age of stratified medicine, this study provides clear
evidence to support weight change advice for specific patient
subgroups. Women who are underweight in their first pregnancy
should be advised to gain weight as even a modest increase is
associated with a reduction in the risk of IUGR. Admittedly, this is
also associated with an increased risk of PE but given the low
background risk of this condition within this patient group, the
benefits outweigh the risks. Weight reduction in overweight and
women with obesity however is not associated with similar
benefits. These women would need to lose an extraordinary
amount of weight to achieve the same reduction of PE risk.
Similarly, BMI change in women with a history of PE or IUGR
appears to generate marginal effects on their risk of complication
recurrence and should perhaps be managed with close monitor-
ing and aspirin administration [35]. In a recent study, metformin
has shown initial promise in preventing early-onset PE in high-risk
women and is perhaps also worth considering as a management
option [36].
Clinical implications
Currently, NICE (National Institute of Clinical Excellence) guidelines
suggest that women with a BMI higher than 30 kg/m2 at their
postnatal check-up are referred for weight loss advice [35].
However, the results presented here demonstrate that a previous
history of complication, and moderate changes in BMI between
the first and second pregnancy, can lead to an altered risk of
adverse pregnancy outcomes such as PE and IUGR. This indicates
that advice regarding weight loss or weight gain should be
tailored to individual women based on their early pregnancy BMI
category and the background risk of pregnancy complications
such as PE or IUGR. For example, a woman in the underweight BMI
category at the time of the first pregnancy should be advised to
gain weight for the second pregnancy as this would be beneficial
in reducing her risk of having an IUGR baby. Although weight gain
in this category of women may increase their risk of developing
PE, the risk in this patient subgroup has been found to be of minor
concern [24]. The reverse is true for weight loss and IUGR, where
the risk is known to be high [19, 24]. As highlighted in a relatively
recent systematic review and meta-analysis, there is a significant
deficit of relevant and high-quality studies investigating inter-
pregnancy weight change and adverse pregnancy outcomes
including PE risk [37]. Therefore, the results presented here will
help to improve the understanding of the impact of interpreg-
nancy weight change on the risk of PE and IUGR and will help
provide evidence-based weight guidance to enable better risk
stratification of women.
CONCLUSION
In this cohort study using a combined data set from three different
countries, we found an increased risk of PE and high birthweight
(>4000 g) with an interpregnancy BMI increase of ≥2 kg/m2.
However, an increased BMI between the first and second
pregnancies reduced the rate of IUGR. Other than reducing the
risk of a high birthweight and instrumental delivery, weight loss
between pregnancies did not confer any reduction in the risk of
adverse perinatal outcomes but increased the risk of IUGR and
preterm delivery. There was very little benefit of weight loss seen
in high-risk groups such as women with obesity or women with a
previous history of pregnancy complications. Women who were in
the underweight category at the start of their first pregnancy were
most sensitive to interpregnancy BMI change.
Ultimately, interpregnancy weight change has a modest
influence on the risk of the most clinically significant outcomes,
PE and IUGR, in differing directions. Prior history of these
conditions has the strongest influence on the likelihood of
occurrence in the second pregnancy. Therefore, interpregnancy
weight change advice between the first and second pregnancy
should be tailored to each patient based on their BMI and
previous pregnancy history to help benefit maternal and offspring
health.
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